Oasis Pharmaceuticals

Continuus Pharmaceuticals Inc, located in Woburn, MA, specializes in Integrated Continuous Manufacturing (ICM) solutions for the production of small molecule drugs. Their innovative approach offers a range of targeted solutions that enhance efficiencies across the pharmaceutical supply chain, addressing specific client needs through flexible and modular manufacturing processes. By collaborating with government agencies and leading global companies, Continuus Pharmaceuticals is at the forefront of advancements in continuous manufacturing. Their commitment to innovation is reflected in various case studies and scientific publications that highlight the impact of their technologies on the pharmaceutical industry. Generated from the website

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Tedor Pharma Inc is a US-based contract development and manufacturing organization (CDMO) specializing in the reliable manufacture of high-quality solid dose pharmaceuticals and controlled substances. With over 20 years of experience, their comprehensive and flexible services, from formulation development to commercial manufacturing, ensure speed, quality, and efficiency in delivering pharmaceutical products to patients. Located in Cumberland, RI, just an hour south of Boston, MA, Tedor Pharma's state-of-the-art facility is FDA registered and inspected, and DEA licensed to manufacture controlled substances. Their expert staff provides end-to-end outsourcing solutions, including clinical trial services, analytical services, and GMP manufacturing, making them a trusted partner for small molecule drug product development.Generated from the website